Hutzel Women's Hospital
Detroit, Michigan, 48201, United States
NCT Number: NCT00342550
Preterm labor is a leading cause of perinatal morbidity and mortality. Several investigators have reported that ultrasound evaluation of the cervix can predict the risk of preterm delivery. Three-dimensional ultrasound may provide additional information about how to best counsel parents about the chances of premature birth. This technology has the capability for accurate volume measurements of irregular structures that is superior to conventional ultrasound. Therefore, it is possible that three-dimensional ultrasound methods may better characterize cervical changes and the risk for preterm delivery.
Our protocol will attempt to identify prognostic indicators of adverse pregnancy outcome by three-dimensional ultrasound. A maximum of 680 pregnant women with the diagnosis of preterm labor will be prospectively studied to characterize cervical morphology and volume as predictors of preterm delivery risk. These results will be correlated with placental pathology and pregnancy outcome. We will also compare the performance of conventional two-dimensional endovaginal ultrasound with three-dimensional ultrasound findings. This information is expected to improve our understanding about the nature and timing of cervical volume changes in relation to pregnancy outcome.
Looking for future studies?
Notify Me15 year and older
Female
Observational
Detroit, Michigan, 48201, United States
Preterm labor is a leading cause of perinatal morbidity and mortality. Several investigators have reported that ultrasound evaluation of the cervix can predict the risk of preterm delivery. Three-dimensional ultrasound may provide additional information about how to best counsel parents about the chances of premature birth. This technology has the capability for accurate volume measurements of irregular structures that is superior to conventional ultrasound. Therefore, it is possible that three-dimensional ultrasound methods may better characterize cervical changes and the risk for preterm delivery.
Our protocol will attempt to identify prognostic indicators of adverse pregnancy outcome by three-dimensional ultrasound. A maximum of 680 pregnant women with the diagnosis of preterm labor will be prospectively studied to characterize cervical morphology and volume as predictors of preterm delivery risk. These results will be correlated with maternal and fetal biological markers, placental pathology and pregnancy outcome. We will also compare the performance of conventional two-dimensional endovaginal ultrasound with three-dimensional ultrasound findings. This information is expected to improve our understanding about the nature and timing of cervical volume changes in relation to pregnancy outcome.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
3 Intact membranes;
Exclusion criteria
- PRETERM LABOR AND INTACT MEMBRANES:
Inclusion criteria
- PATIENTS AT RISK FOR PRETERM DELIVERY:
Exclusion criteria
- PATIENTS AT RISK FOR PRETERM DELIVERY:
Inclusion criteria
- PATIENTS IN SPONTANEOUS LABOR AT TERM:
Exclusion criteria
- PATIENTS IN SPONTANEOUS LABOR AT TERM:
Inclusion criteria
- PATIENTS UNDERGOING ELECTIVE INDUCTION OF LABOR:
Exclusion criteria
- PATIENTS UNDERGOING ELECTIVE INDUCTION OF LABOR:
Time frame: Ongoing
Data analysis is ongoing
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03480139
Death, Female Urogenital Diseases and Pregnancy Complications
Detroit, Michigan, United States
View Trial DetailsNCT00340249
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Bethesda, Maryland, United States
View Trial DetailsNCT00339235
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Detroit, Michigan, United States
View Trial DetailsNCT00342667
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Bethesda, Maryland, United States
View Trial Details